219 related articles for article (PubMed ID: 27613044)
1. Dissecting SUMO Dynamics by Mass Spectrometry.
Drabikowski K; Dadlez M
Methods Mol Biol; 2016; 1449():291-8. PubMed ID: 27613044
[TBL] [Abstract][Full Text] [Related]
2. Identification of Substrates of Protein-Group SUMOylation.
Psakhye I; Jentsch S
Methods Mol Biol; 2016; 1475():219-31. PubMed ID: 27631809
[TBL] [Abstract][Full Text] [Related]
3. Label-Free Identification and Quantification of SUMO Target Proteins.
Hendriks IA; Vertegaal AC
Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806
[TBL] [Abstract][Full Text] [Related]
4. Identification of SUMO target proteins by quantitative proteomics.
Andersen JS; Matic I; Vertegaal AC
Methods Mol Biol; 2009; 497():19-31. PubMed ID: 19107408
[TBL] [Abstract][Full Text] [Related]
5. The post-translational modification, SUMOylation, and cancer (Review).
Han ZJ; Feng YH; Gu BH; Li YM; Chen H
Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374
[TBL] [Abstract][Full Text] [Related]
6. Identification of SUMO-conjugated proteins and their SUMO attachment sites using proteomic mass spectrometry.
Wohlschlegel JA
Methods Mol Biol; 2009; 497():33-49. PubMed ID: 19107409
[TBL] [Abstract][Full Text] [Related]
7. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
[TBL] [Abstract][Full Text] [Related]
8. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
9. Mapping the SUMOylated landscape.
Eifler K; Vertegaal AC
FEBS J; 2015 Oct; 282(19):3669-80. PubMed ID: 26185901
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SUMOylated Proteins in Cells and In Vivo Using the bioSUMO Strategy.
Pirone L; Xolalpa W; Mayor U; Barrio R; Sutherland JD
Methods Mol Biol; 2016; 1475():161-9. PubMed ID: 27631805
[TBL] [Abstract][Full Text] [Related]
11. Detection of SUMOylated Phytochromes in Plants.
Orosa B; Viczián A
Methods Mol Biol; 2019; 2026():69-83. PubMed ID: 31317403
[TBL] [Abstract][Full Text] [Related]
12. A Chemical and Enzymatic Approach to Study Site-Specific Sumoylation.
Albuquerque CP; Yeung E; Ma S; Fu T; Corbett KD; Zhou H
PLoS One; 2015; 10(12):e0143810. PubMed ID: 26633173
[TBL] [Abstract][Full Text] [Related]
13. Site-specific identification and quantitation of endogenous SUMO modifications under native conditions.
Lumpkin RJ; Gu H; Zhu Y; Leonard M; Ahmad AS; Clauser KR; Meyer JG; Bennett EJ; Komives EA
Nat Commun; 2017 Oct; 8(1):1171. PubMed ID: 29079793
[TBL] [Abstract][Full Text] [Related]
14. Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.
Filosa G; Barabino SM; Bachi A
Neuromolecular Med; 2013 Dec; 15(4):661-76. PubMed ID: 23979992
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
[TBL] [Abstract][Full Text] [Related]
16. Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis.
Subramonian D; Raghunayakula S; Olsen JV; Beningo KA; Paschen W; Zhang XD
J Proteome Res; 2014 Sep; 13(9):3905-18. PubMed ID: 25072996
[TBL] [Abstract][Full Text] [Related]
17. Site-specific proteomic strategies to identify ubiquitin and SUMO modifications: Challenges and opportunities.
Trulsson F; Vertegaal ACO
Semin Cell Dev Biol; 2022 Dec; 132():97-108. PubMed ID: 34802913
[TBL] [Abstract][Full Text] [Related]
18. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE
Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256
[TBL] [Abstract][Full Text] [Related]
19. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
[TBL] [Abstract][Full Text] [Related]
20. The role of protein SUMOylation in rheumatoid arthritis.
Dehnavi S; Sadeghi M; Johnston TP; Barreto G; Shohan M; Sahebkar A
J Autoimmun; 2019 Aug; 102():1-7. PubMed ID: 31078376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
